Notice of Intent to Publish a Funding Opportunity Announcement for Innovative Therapies and Tools for Screenable Disorders in Newborns
Notice Number:
NOT-HD-21-039

Key Dates

Release Date:
June 01, 2021
Estimated Publication Date of Funding Opportunity Announcement:
July 01, 2021
First Estimated Application Due Date:
October 01, 2021
Earliest Estimated Award Date:
July 01, 2022
Earliest Estimated Start Date:
July 01, 2022
Related Announcements

PAR-18-689 - Innovative Therapies and Tools for Screenable Disorders in Newborns (R01 - Clinical Trial Optional)

PAR-18-690 - Innovative Therapies and Tools for Screenable Disorders in Newborns (R03 Clinical Trial Optional)

PAR-18-691 - Innovative Therapies and Tools for Screenable Disorders in Newborns (R21 Clinical Trial Optional)

Issued by

Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)

Purpose

The purpose of this Notice is to inform the scientific community that the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) plans to reissue three Funding Opportunity Announcements (FOAs), PAR-18-689, PAR-18-690, and PAR-18-691, “Innovative Therapies and Tools for Screenable Disorders in Newborns. When reissued, these FOAs will continue to use the R01, R03, and R21 activity codes, respectively, and will continue to be clinical trial optional. The Specific Areas of Research Interest in these FOAs will be updated to include new and revised research priorities.

This Notice informs potential applicants of the future availability of continued opportunities to submit applications beyond the May 8, 2021 expiration of the FOAs.

The FOAs are expected to be published in Summer 2021, with the first application due dates in Fall 2021.

Research Initiative Details

These FOAs encourage research relevant to the development of therapeutic interventions for potentially fatal or disabling conditions that have been identified through newborn screening, as well as "high priority" genetic conditions where screening may be possible in the near future.

Demonstrating the benefits of treatment is often a primary criterion for including a condition on a newborn screening panel; therefore, for these FOAs, a "high priority" condition is one where screening is not currently recommended but would significantly benefit from early identification and treatment.

Funding Information
Estimated Total Funding

TBD

Expected Number of Awards
TBD
Estimated Award Ceiling

TBD

Primary Assistance Listing Number(s)

TBD

Anticipated Eligible Organizations
Public/State Controlled Institution of Higher Education
Private Institution of Higher Education
Nonprofit with 501(c)(3) IRS Status (Other than Institution of Higher Education)
Small Business
For-Profit Organization (Other than Small Business)
State Government
Indian/Native American Tribal Government (Federally Recognized)
County governments
Independent school districts
Public housing authorities/Indian housing authorities
Indian/Native American Tribally Designated Organization (Native American tribal organizations (other than Federally recognized tribal governments)
U.S. Territory or Possession
Indian/Native American Tribal Government (Other than Federally Recognized)
Non-domestic (non-U.S.) Entity (Foreign Organization)
Regional Organization

Applications are not being solicited at this time. 

Inquiries

Please direct all inquiries to:

Mollie Minear, PhD

Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)

301-827-9442

mollie.minear@nih.gov


Weekly TOC for this Announcement
NIH Funding Opportunities and Notices